Science Explorer Back to mapMap
Discussion
Company · Slough · United Kingdom

UCB Pharma (United Kingdom)

In research, UCB Pharma (United Kingdom) stands highest in Life Sciences (#1,320 of 11,023 worldwide), Health Sciences (#2,028 of 16,688 worldwide) and Medicine (#2,010 of 14,558 worldwide), over all time.

ucbpharma.co.uk/homeROR OpenAlex
World rank, 2022-now
#12,244
of 22,385 · #3,505 all time
Rank in United Kingdom
#404
of 862
Research works
722
◆ 2% vs 2018-21
Citations
31k
42.6 per fractional work
Top-10% rate
13.0%
all institutions 10.0%
vs its own fields
1.01×
1.00× is exactly expected
Open access
47%
world 40%
International
39%
world 18%
UCB Pharma (United Kingdom)

What is UCB Pharma (United Kingdom) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #1,320 of 11,023 14.4%327
Health SciencesDomain #2,028 of 16,688 16.5%273
MedicineField #2,010 of 14,558 16.4%263
Biochemistry, Genetics and Molecular BiologyField #1,143 of 5,801 15.4%211
Molecular BiologySubfield #994 of 3,729 13.7%155

Each strip is that field's whole ranked pool, with the notch where UCB Pharma (United Kingdom) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does UCB Pharma (United Kingdom) work in?

In 2022-now, 51% of research at UCB Pharma (United Kingdom) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (49%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (12%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 57 fractional works · 50.8% of its workMedicine: 56 fractional works · 49.4% of its workRheumatology: 11 fractional works · 10.0% of its workNeurology: 8 fractional works · 7.0% of its workOncology: 4 fractional works · 3.7% of its workDermatology: 4 fractional works · 3.7% of its workRadiology, Nuclear Medicine and Imaging: 4 fractional works · 3.6% of its workSurgery: 3 fractional works · 2.6% of its workPathology and Forensic Medicine: 2 fractional works · 2.1% of its workPsychiatry and Mental health: 2 fractional works · 1.8% of its workPulmonary and Respiratory Medicine: 2 fractional works · 1.5% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 1.4% of its workGenetics: 1 fractional works · 1.3% of its workEpidemiology: 1 fractional works · 1.2% of its workHematology: 1 fractional works · 1.1% of its workPhysiology: 1 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 1.0% of its workOrthopedics and Sports Medicine: 1 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.9% of its workNephrology: 1 fractional works · 0.8% of its workInfectious Diseases: 1 fractional works · 0.7% of its workPharmacology: 1 fractional works · 0.7% of its workHepatology: 1 fractional works · 0.5% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workUrology: 0 fractional works · 0.3% of its workFamily Practice: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.7% of its workHealth Professions: 1 fractional works · 1.0% of its workGeneral Health Professions: 1 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.3% of its workOral Surgery: 0 fractional works · 0.3% of its workNursing: 0 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 34 fractional works · 30.1% of its workBiochemistry, Genetics and Molecular Biology: 16 fractional works · 14.2% of its workMolecular Biology: 11 fractional works · 9.7% of its workGenetics: 3 fractional works · 2.6% of its workCancer Research: 1 fractional works · 0.7% of its workCell Biology: 1 fractional works · 0.6% of its workBiophysics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 13 fractional works · 11.7% of its workImmunology: 13 fractional works · 11.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 2.2% of its workCellular and Molecular Neuroscience: 2 fractional works · 1.3% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workCognitive Neuroscience: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 1.5% of its workPharmacology: 1 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 0.5% of its workInsect Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 12 fractional works · 10.6% of its workEngineering: 4 fractional works · 3.2% of its workBiomedical Engineering: 1 fractional works · 1.2% of its workCivil and Structural Engineering: 1 fractional works · 0.9% of its workOcean Engineering: 1 fractional works · 0.7% of its workAerospace Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workChemistry: 2 fractional works · 2.1% of its workOrganic Chemistry: 1 fractional works · 1.2% of its workSpectroscopy: 1 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMathematics: 2 fractional works · 1.9% of its workStatistics and Probability: 2 fractional works · 1.9% of its workEarth and Planetary Sciences: 2 fractional works · 1.5% of its workGeophysics: 1 fractional works · 1.1% of its workOceanography: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 1 fractional works · 1.3% of its workComputational Theory and Mathematics: 1 fractional works · 0.8% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workEnergy: 0 fractional works · 0.1% of its workSocial Sciences: 10 fractional works · 8.5% of its workEconomics, Econometrics and Finance: 5 fractional works · 4.7% of its workEconomics and Econometrics: 5 fractional works · 4.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 3 fractional works · 2.7% of its workHealth: 1 fractional works · 0.9% of its workAnthropology: 1 fractional works · 0.6% of its workGeography, Planning and Development: 0 fractional works · 0.3% of its workPolitical Science and International Relations: 0 fractional works · 0.3% of its workUrban Studies: 0 fractional works · 0.3% of its workEducation: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workDecision Sciences: 1 fractional works · 0.7% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.4% of its workManagement Science and Operations Research: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workBusiness, Management and Accounting: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.1% of its workArts and Humanities: 0 fractional works · 0.1% of its workALL ITS WORKUCB Pharma(United Kingdom)113fractional works, 2022-now
Life Sciences30%Physical Sciences11%Health Sciences51%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 25 fields, with their numbers
    1. Medicine5649.4%
    2. Health Professions11.0%
    3. Dentistry00.3%
    4. Nursing00.1%
    5. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology1614.2%
    2. Immunology and Microbiology1311.7%
    3. Neuroscience22.2%
    4. Pharmacology, Toxicology and Pharmaceutics21.5%
    5. Agricultural and Biological Sciences10.5%
    1. Engineering43.2%
    2. Chemistry22.1%
    3. Mathematics21.9%
    4. Earth and Planetary Sciences21.5%
    5. Computer Science11.3%
    6. Materials Science00.3%
    7. Environmental Science00.1%
    8. Physics and Astronomy00.1%
    9. Energy00.1%
    1. Economics, Econometrics and Finance54.7%
    2. Social Sciences32.7%
    3. Decision Sciences10.7%
    4. Business, Management and Accounting00.2%
    5. Psychology00.1%
    6. Arts and Humanities00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.66× its world share, 16 worksBiochemistry, Geneti…Immunology and Microbiology: 11.65× its world share, 13 worksImmunology and Micro…Neuroscience: 1.34× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.23× its world share, 2 worksPharmacology, Toxico…Chemistry: 1.35× its world share, 2 worksChemistryComputer Science: 0.17× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.94× its world share, 2 worksEarth and Planetary …Energy: 0.08× its world share, 0 worksEnergyEngineering: 0.22× its world share, 4 worksEngineeringEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials ScienceMathematics: 1.60× its world share, 2 worksMathematicsPhysics and Astronomy: 0.04× its world share, 0 worksPhysics and AstronomyDentistry: 0.66× its world share, 0 worksDentistryHealth Professions: 0.37× its world share, 1 worksHealth ProfessionsMedicine: 2.57× its world share, 56 worksMedicineNursing: 0.20× its world share, 0 worksNursingVeterinary: 0.36× its world share, 0 worksVeterinaryArts and Humanities: 0.02× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.06× its world share, 0 worksBusiness, Management…Decision Sciences: 0.74× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 2.20× its world share, 5 worksEconomics, Econometr…Psychology: 0.02× its world share, 0 worksPsychologySocial Sciences: 0.22× its world share, 3 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.7×. Every wedge is a field page.

All 25 fields, with their numbers
  1. Immunology and Microbiology11.65×13 works
  2. Pharmacology, Toxicology and Pharmaceutics4.23×2 works
  3. Biochemistry, Genetics and Molecular Biology2.66×16 works
  4. Medicine2.57×56 works
  5. Economics, Econometrics and Finance2.20×5 works
  6. Mathematics1.60×2 works
  7. Chemistry1.35×2 works
  8. Neuroscience1.34×2 works
  9. Earth and Planetary Sciences0.94×2 works
  10. Decision Sciences0.74×1 works
  11. Dentistry0.66×0 works
  12. Health Professions0.37×1 works
  13. Veterinary0.36×0 works
  14. Engineering0.22×4 works
  15. Social Sciences0.22×3 works
  16. Nursing0.20×0 works
  17. Computer Science0.17×2 works
  18. Agricultural and Biological Sciences0.11×1 works
  19. Energy0.08×0 works
  20. Materials Science0.08×0 works
  21. Business, Management and Accounting0.06×0 works
  22. Physics and Astronomy0.04×0 works
  23. Environmental Science0.02×0 works
  24. Arts and Humanities0.02×0 works
  25. Psychology0.02×0 works

Who are the top researchers at UCB Pharma (United Kingdom)?

Ranked on the quality score, Andrew Docherty, Sue Stephens and J.S. Emtage lead among researchers whose main affiliation is UCB Pharma (United Kingdom).

  1. 1 Andrew Docherty United Kingdom · #148,380 worldwide 12k citations · 133 works
  2. 2 Sue Stephens United Kingdom · #221,160 worldwide 4.6k citations · 53 works
  3. 3 J.S. Emtage United Kingdom · #242,227 worldwide 3.1k citations · 45 works
  4. 4 Jay Tibbitts United Kingdom · #258,225 worldwide 4.3k citations · 121 works
  5. 5 TERRY S. BAKER United Kingdom · #306,569 worldwide 3.1k citations · 49 works
  6. 6 Paul E. Stephens United Kingdom · #309,237 worldwide 6k citations · 62 works
  7. 7 Owen R Davies United Kingdom · #312,925 worldwide 3.3k citations · 92 works
  8. 8 Mark Bodmer United Kingdom · #324,298 worldwide 2.8k citations · 48 works
  9. 9 Alastair D. G. Lawson United Kingdom · #387,841 worldwide 7k citations · 73 works
  10. 10 Geoffrey I. Johnston United Kingdom · #407,140 worldwide 2.9k citations · 38 works
All ranked researchers at UCB Pharma (United Kingdom)

What are the most cited papers from UCB Pharma (United Kingdom)?

The most cited paper from UCB Pharma (United Kingdom) is "Natural products in drug discovery: advances and opportunities" (Atanas G. Atanasov et al., 2021), with 5,395 citations. Next come "Rings in Drugs" (2,540) and "Organic synthesis provides opportunities to transform drug discovery" (1,554).

Most cited papers
#PaperReleasedCitations
1 Natural products in drug discovery: advances and opportunities Atanas G. Atanasov et al. · Nature Reviews Drug Discovery ReviewOpen access 28 Jan 2021 5,395
2 Rings in Drugs Richard D. Taylor, Malcolm MacCoss, Alastair D. G. Lawson · Journal of Medicinal Chemistry 28 Jan 2014 2,540
3 Organic synthesis provides opportunities to transform drug discovery David C. Blakemore, Luis C. Misal Castro, Ian Churcher et al. · Nature Chemistry 22 Mar 2018 1,554
4 Certolizumab Pegol for the Treatment of Crohn's Disease William J. Sandborn, Brian G. Feagan, Simeon Stoinov et al. · New England Journal of Medicine Open access 18 Jul 2007 1,146
5 Maintenance Therapy with Certolizumab Pegol for Crohn's Disease Stefan Schreiber, Mani Khaliq-Kareemi, Ian Craig Lawrance et al. · New England Journal of Medicine 18 Jul 2007 1,050
All 59 most cited papers, with filters and sorting

Which keywords describe research at UCB Pharma (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Autoantibodies, TGF-ß, Regulatory T Cells, Immune System, Inflammation, IL-17, TH17 Cells and Monoclonal Antibodies.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Autoantibodies11▲ 41×8 topics
  2. Inflammation10▲ 4.1×29 topics
  3. Epidemiology9▲ 1.99×30 topics
  4. TGF-ß9▲ 47×4 topics
  5. Regulatory T Cells8▲ 65×4 topics
  6. Immune System8▲ 31×4 topics
  7. Quality of Life8▲ 4.7×9 topics
  8. IL-177▲ 176×1 topic
  9. TH17 Cells7▲ 176×1 topic
  10. Monoclonal Antibodies6▲ 61×3 topics
  11. Immunotherapy5▲ 6.2×8 topics
  12. Ankylosing Spondylitis5▲ 150×1 topic
  13. Cancer5▲ 3.3×20 topics
  14. Spondyloarthritis5▲ 150×1 topic
  15. Glycosylation5▲ 39×3 topics
  16. Prognosis5▲ 13×4 topics
  17. Therapeutic Antibodies4▲ 58×2 topics
  18. Cytokines4▲ 13×4 topics
  19. Neurological Disorders4▲ 6.4×11 topics
  20. Neuromuscular Junction4▲ 88×2 topics
  21. Rheumatoid Arthritis4▲ 37×2 topics
  22. Myasthenia Gravis4▲ 178×1 topic
  23. Thymic Tumors4▲ 178×1 topic
  24. Biological Therapy4▲ 58×1 topic
  25. Cardiovascular Risk4▲ 11×2 topics
  26. Disease-Modifying Antirheumatic Drugs4▲ 66×1 topic
  27. Cost-effectiveness Analysis4▲ 41×1 topic
  28. Health Utility Measures4▲ 41×1 topic
  29. Treatment4▲ 2.6×19 topics
  30. Antibody Engineering3▲ 55×1 topic
  31. Fc Receptors3▲ 55×1 topic
  32. Immunosuppressive Therapy3▲ 15×6 topics
  33. Biomarkers3▲ 4.0×7 topics
  34. Genetics3▲ 3.8×9 topics
  35. Biopharmaceuticals3▲ 49×3 topics
  36. Immunogenicity3▲ 58×2 topics
  37. Parkinson's Disease3▲ 9.8×6 topics
  38. Clinical Outcomes2▲ 8.9×2 topics
  39. Diagnostic Criteria2▲ 8.0×6 topics
  40. Genetic Susceptibility2▲ 18×2 topics

Which research topics does UCB Pharma (United Kingdom) publish most on?

By volume in 2022-now: Psoriasis: Treatment and Pathogenesis, Spondyloarthritis Studies and Treatments, Myasthenia Gravis and Thymoma and Rheumatoid Arthritis Research and Therapies.

Psoriasis: Treatment and…7Psoriasis: Treatment and Pathogenesis: 7 fractional worksSpondyloarthritis Studies and Treatments: 5 fractional worksMyasthenia Gravis and Th…4Myasthenia Gravis and Thymoma: 4 fractional worksRheumatoid Arthritis Res…4Rheumatoid Arthritis Research and Therapies: 4 fractional worksHealth Systems, Economic…4Health Systems, Economic Evaluations, Quality of Life: 4 fractional worksMonoclonal and Polyclona…3Monoclonal and Polyclonal Antibodies Research: 3 fractional worksHidradenitis Suppurativa and Treatments: 2 fractional worksBiosimilars and Bioanalytical Methods: 2 fractional worksStatistical Methods in Clinical Trials: 1 fractional worksSystemic Lupus Erythematosus Research: 1 fractional works
ImmunologyRheumatologyNeurologyEconomics and Econometrics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Psoriasis: Treatment and Pathogenesis Immunology 7 works
  2. 2 Spondyloarthritis Studies and Treatments Rheumatology 5 works
  3. 3 Myasthenia Gravis and Thymoma Neurology 4 works
  4. 4 Rheumatoid Arthritis Research and Therapies Rheumatology 4 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  7. 7 Hidradenitis Suppurativa and Treatments Dermatology 2 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 2 works
  9. 9 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  10. 10 Systemic Lupus Erythematosus Research Rheumatology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.8%not open53.2%

World: 40% of research is openly available.

with international co-authors38.8%domestic only61.2%

World: 18% is written across borders.

How has UCB Pharma (United Kingdom)'s research output changed?

Output in 2022-2025 was 2% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is UCB Pharma (United Kingdom) as a percentage of every work published that year, 0.00055% in 2024.

still counting0.0020%0.0040%UCB Pharma (United Kingdom)0.00023% in 202519801990200020102020

Fractional works of UCB Pharma (United Kingdom) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

10%20%30%all institutions10.0% in 2024UCB Pharma (United Kingdom)9.2% in 2024200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 24.2% in 2015.

Other research institutions in Slough

All research institutions in Slough

Share UCB Pharma (United Kingdom)'s ranking

UCB Pharma (United Kingdom) on Science Explorer

A card with UCB Pharma (United Kingdom)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about UCB Pharma (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.